Latest Stories
View all →The National Children's Hospital Has Missed 19 Completion Deadlines — But the End Is Finally in Sight
A €650 million project that became a €2.2 billion national conversation. Inside the delays, the defects, and the final push to open the country's most important hospital.
Novo Nordisk Invests €432 Million in Athlone to Make the Wegovy Pill for the World
A new tableting facility at the Monksland site will supply the oral Wegovy formulation to Europe and other international markets — a direct bet on the global rollout of the GLP-1 tablet.
Ireland's Biopharma Exports Hit €99.9 Billion — While Cutting Carbon Emissions by 30%
Irish pharmaceutical exports reached €99.9 billion in 2024 while electricity-related carbon emissions fell by 30.5%. What the numbers mean for the sector, the climate, and Ireland's EU presidency.
Ireland's National Life Sciences Strategy Is Coming — And the Stakes Have Never Been Higher
Ireland's first National Life Sciences Strategy is expected before the end of June 2026. Why it matters for the sector, the EU Presidency, and Ireland's €100 billion life sciences economy.
Ireland's life sciences sector is worth €100bn to the economy — and it's still growing
From diagnostics to drug discovery, medical devices to biologics manufacturing, Ireland has quietly become one of the world's most important life sciences hubs. We examine what built it, what sustains it, and what could undermine it.
Galway, Medtronic and Boston Scientific: Why Ireland's Medtech Capital Is Doubling Down
Two major announcements from Medtronic and Boston Scientific in 2026 signal that Ireland's medtech position is not being reconsidered — it is being deepened. Alongside them, a new generation of indigenous companies is emerging.
Emergency department overcrowding: the data, the causes and the international comparisons
Ireland's ED wait times are among the worst in the developed world. A deep dive into what's driving the crisis — and what other health systems have done to fix it.
The Irish nurses and doctors leaving for Australia — and the structural reasons they won't come back
Competitive pay is only part of the story. Working conditions, career progression and quality of life all feature in exit interviews with healthcare workers who've emigrated.
RCSI's cancer research breakthrough: what it means and when it could reach patients
A new immunotherapy approach developed in Dublin has shown exceptional results in early trials. We speak to the lead researcher about the road from lab to clinic.